Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)

Condition:   HIV Infections Intervention:   Sponsors:   ANRS, Emerging Infectious Diseases;   CIRBA, Abidjan, Ivory Coast;   SEREFO, Bamako, Mali;   BIOLIM/FSS/UL, Lomé, Togo Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials